Nareg Varjabedian/LinkedIn
Nov 20, 2024, 19:12
Nareg Varjabedian: Antidiabetic Drugs and Cancer Prevention
Nareg Varjabedian, Regulatory Affairs Team Lead at ClinChoice, shared a post on LinkedIn:
“New Article Alert: Antidiabetic Drugs and Cancer Prevention – A Comprehensive Review.
I’m thrilled to share my latest article exploring the intriguing connection between antidiabetic drugs and their potential role in cancer prevention. This comprehensive review delves into the current research, mechanisms of action, and clinical implications, highlighting how these medications might contribute to reducing cancer risk.
Join me in uncovering the multifaceted benefits of antidiabetic drugs and their impact on public health.”
For more posts like this, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 12:57
Nov 21, 2024, 12:54
Nov 21, 2024, 12:49
Nov 21, 2024, 12:36
Nov 21, 2024, 09:55
Nov 21, 2024, 09:28
Nov 21, 2024, 09:23
Nov 21, 2024, 09:04